Published in Am J Respir Cell Mol Biol on March 01, 2000
NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation. J Biol Chem (2007) 1.44
Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer. Hypertension (2009) 1.32
Cancer, inflammation and the AT1 and AT2 receptors. J Inflamm (Lond) (2004) 1.11
Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. Br J Pharmacol (2009) 1.01
Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol (2015) 0.92
Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy. Cardiovasc Hematol Disord Drug Targets (2010) 0.87
Specific single chain variable fragment (ScFv) antibodies to angiotensin II AT(2) receptor: evaluation of the angiotensin II receptor expression in normal and tumor-bearing mouse lung. J Mol Histol (2008) 0.86
Effects of olmesartan, an AT1 receptor antagonist, on hypoxia-induced activation of ERK1/2 and pro-inflammatory signals in the mouse lung. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.82
Molecular and clinical analysis of TRPC6 and AGTR1 genes in patients with pulmonary arterial hypertension. Orphanet J Rare Dis (2015) 0.81
Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease. BMC Cardiovasc Disord (2009) 0.81
Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease. Respir Res (2005) 0.81
Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs. Crit Care (2004) 0.81
Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy. Curr Bioact Compd (2010) 0.80
Increased angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted mice. Regul Pept (2009) 0.80
Determination of PKC isoform-specific protein expression in pulmonary arteries of rats with chronic hypoxia-induced pulmonary hypertension. Med Sci Monit (2012) 0.80
Increased expression of endothelin ET(B) and angiotensin AT(1) receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome. Heart Vessels (2009) 0.80
Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system. Braz J Med Biol Res (2012) 0.76
Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system. BMC Cardiovasc Disord (2016) 0.75
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest (2001) 2.59
Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med (1992) 2.56
Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ Res (1981) 2.20
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J (2005) 1.98
Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest (1991) 1.91
Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med (1999) 1.91
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation (2005) 1.84
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest (2000) 1.80
Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood (2001) 1.51
Quantitative systolic and diastolic transmyocardial velocity gradients assessed by M-mode colour Doppler tissue imaging as reliable indicators of regional left ventricular function after acute myocardial infarction. Eur Heart J (1999) 1.49
Repeated coronary artery occlusions during routine balloon angioplasty do not induce myocardial preconditioning in humans. J Am Coll Cardiol (1996) 1.49
Alteration of left ventricular diastolic function during coronary angioplasty-induced ischemia: a color M-mode Doppler study. J Am Coll Cardiol (1997) 1.47
Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure. Am J Respir Crit Care Med (1997) 1.46
Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schönlein purpura. Preliminary results of a prospective uncontrolled trial. Nephron (1995) 1.45
5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol (2000) 1.42
Motional ordering of a charge-density wave in the sliding state. Phys Rev Lett (2002) 1.42
Results and follow-up after percutaneous pulsed laser-assisted balloon angioplasty guided by spectroscopy. Circulation (1991) 1.40
Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res (1990) 1.39
Case 4-1993. Inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiothorac Vasc Anesth (1993) 1.39
Effects of bradykinin on coronary blood flow and vasomotion in transplant patients. J Am Coll Cardiol (2000) 1.39
Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res (1999) 1.37
Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J (2001) 1.26
Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. Br J Pharmacol (1997) 1.23
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation (1999) 1.21
Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur Respir J (2005) 1.17
Extracellular matrix and growth factors during heart growth. Heart Fail Rev (2000) 1.15
Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J (2001) 1.15
Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am J Physiol (1997) 1.14
Cytoskeleton and mitochondrial morphology and function. Mol Cell Biochem (1998) 1.14
Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol (2000) 1.13
Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am J Respir Cell Mol Biol (2000) 1.12
Study of regulation of mitochondrial respiration in vivo. An analysis of influence of ADP diffusion and possible role of cytoskeleton. Biochim Biophys Acta (1997) 1.12
Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ Res (1997) 1.12
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J (2006) 1.11
Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. Eur Respir J (2009) 1.11
Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest (1996) 1.10
A pathogenic paramyxovirus from a budgerigar (Melopsittacus undulatus). Avian Dis (1974) 1.10
Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Am J Physiol (1998) 1.10
Microtubules and desmin filaments during onset of heart hypertrophy in rat: a double immunoelectron microscope study. Circ Res (1987) 1.09
Distribution of myosin isozymes within single cardiac cells. An immunohistochemical study. Circ Res (1983) 1.09
Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing. Br J Pharmacol (2000) 1.09
Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest (1994) 1.07
Apoptosis in target organs of hypertension. Hypertension (1995) 1.05
Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg (2000) 1.05
Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol (1996) 1.03
High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Ann Intern Med (1994) 1.02
Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency. Effects of indomethacin. Chest (1993) 1.02
Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats. Circ Res (2000) 1.01
Differential effects of pressure and flow on DNA and protein synthesis and on fibronectin expression by arteries in a novel organ culture system. Circ Res (1995) 1.01
Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes. Endocrinology (1998) 1.00
Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. Am J Respir Crit Care Med (2000) 1.00
Specific alterations in the distribution of extracellular matrix components within rat myocardium during the development of pressure overload. Lab Invest (1991) 1.00
Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine. Am Rev Respir Dis (1987) 0.99
Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload. J Clin Invest (1991) 0.99
Laminin variants and integrin laminin receptors in developing and adult human smooth muscle. Dev Biol (1993) 0.99
Pathobiology of pulmonary arterial hypertension. Eur Respir J (2002) 0.99
Isolation of Salmonella from mesenteric lymph nodes of healthy cattle at slaughter. Res Vet Sci (1980) 0.99
Synthesis of stress proteins in rat cardiac myocytes 2-4 days after imposition of hemodynamic overload. J Clin Invest (1988) 0.98
Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta. Evidence for a pressure-induced tissue renin-angiotensin system. Circ Res (1996) 0.98
Storage of phosphorylated desmin in a familial myopathy. FEBS Lett (1988) 0.97
Fibronectin expression during physiological and pathological cardiac growth. J Mol Cell Cardiol (1995) 0.96
Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am J Physiol (1995) 0.96
Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. J Pharmacol Exp Ther (2001) 0.95
Potassium channel openers dilate large epicardial coronary arteries in conscious dogs by an indirect, endothelium-dependent mechanism. J Pharmacol Exp Ther (1992) 0.95
Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopenia. Haemostasis (1987) 0.95
Increased expression of fibronectin isoforms after myocardial infarction in rats. J Mol Cell Cardiol (1997) 0.95
Microtubules in cardiac myocytes. Int Rev Cytol (1988) 0.94
Optimal handling of blood samples for routine measurement of lactate and pyruvate. Arch Pathol Lab Med (1994) 0.93
Haemodynamics and gas exchange before and after coil embolization of pulmonary arteriovenous malformations. Eur Respir J (1995) 0.92
Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol (2007) 0.92
Severe hypoxemia-associated intrapulmonary shunt in a patient with chronic liver disease: improvement after medical treatment. Am Rev Respir Dis (1992) 0.92
Role of coronary artery lumen enlargement in improving coronary blood flow after balloon angioplasty and stenting: a combined intravascular ultrasound Doppler flow and imaging study. J Am Coll Cardiol (1997) 0.92
In situ mRNA distribution of sarco(endo)plasmic reticulum Ca(2+)-ATPase isoforms during ontogeny in the rat. J Mol Cell Cardiol (1994) 0.92